 About 55% of cancer drugs introduced between 2019 and 2023 cost at least $200,000 a year. And patients aren't paying all of those costs. Some of that's picked up by insurance. But it just sort of gets at, you know, the financial burden that a lot of these patients are faced with. I believe that medical debt has been the number one cause of personal bankruptcies for a long time. And it doesn't seem that that's changing.